Pylopass™ A new approach in H Pylori control
Pylopass™ is a culture of Lactobacillus reuteri (DSM 17648) containing ≥ 1 x10^11 inactivated cells/gram.
Known by the scientific community, Lactobacillus reuteri is a lactic acid bacterium belonging to the native bacteria in man and animals. It is a rod-shaped, non-spore-forming, Gram-positive bacterium.
Helicobacter pylori is a helix-shaped Gram-negative bacterium that colonises the stomach. This bacterium is now known as the major cause of ulcers and gastritis. It is thought that 50% of the world’s population is infected by this bacterium, more prevalent in developing countries where up to 90% are infected (Go MF, 2002).
According to Kusters et al. (2006), the severity of symptoms is linked to the bacterial load and an untreated ulcer or gastritis can lead to cancer.
Thus, Pylopass™ is a very interesting solution against H. pylori, thanks to a unique mode of action.
RECOMMENDATIONS FOR USE :
1st month : 2 capsules per day after the meal morning and evening
2nd & 3rd month : one capsule per day after breakfast
PRESENTATION:
60 capsules per bottle (bottle sold by 2)
INGREDIENTS :
List of ingredients for 60 capsules:
- Lactobacillus Reuteri (PYLOPASS ™: 200 mg per capsule)
- Plant-based capsule (Hydroxypropylmethylcellulose)
- Maltodextrin, anti-caking agent: magnesium stearate
Lactobacillus reuteri binds specifically to H. pylori in the stomach. The adhesion molecules at the surface of Pylopass™ recognise and adhere to the surface of Helicobacter pylori. Aggregates form in the stomach are then excreted through the digestive tract and eliminated from the body.
To find out more about its mechanism of action
Click below to watch the unique mode of action of Pylopass™
